Oral Drug S-1 Linked to Longer Survival Than Capecitabine in Metastatic Breast Cancer Study
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...
A new scoping review of 30 studies synthesizes the emerging evidence on time toxicity in cancer care, showing how treatment ...
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
A new commentary in Supportive Care in Cancer urges researchers to distinguish between mono-construct and multi-construct uses of latent profile ...
A large Brazilian study of 527 palliative care patients found that older age and reduced Karnofsky performance status independently predict ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
Researchers propose the Lethal Isotherm Ratio, a standardized metric showing how much of a visible cryoablation ice ball is actually ...
A new systematic review and meta-analysis of 21 studies finds that virtual reality interventions significantly reduce anxiety in cancer patients ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine